Cite
MLA Citation
Michael Trauner et al.. “The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.” Hepatology, vol. 70, no. 3, 2019, pp. 788–801. http://access.bl.uk/ark:/81055/vdc_100090082010.0x00003f